Organogenesis Holdings Inc. - Class A (ORGO) analyst actions
Rating and price-target actions on ORGO in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ORGO overview →
3 measured ORGO analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Organogenesis Announces Initiation of Biologics License Application for ReNu® | Press release | +1.04% | +1.56% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Organogenesis Holdings Inc. (ORGO) And Encourages Stockholders to Reach Out | Press release | — | — | |
| Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness | Press release | -2.75% | -0.69% |
Keep exploring
More ORGO: earnings → · SEC filings → · ORGO overview →